Enzymotec announces the appointment of Mr. Ilan Leviteh as the company's acting chairman of the board. "The company believes that Mr. Leviteh's international business profile, management capabilities and the excellent results achieved by companies under his leadership make him the ideal choice." says Enzymotec's spokesman.
Mr. Leviteh for many years and until two years ago, has been the President and CEO of Makhetshim-Agan Industries, the world’s leader of generic agro-chemical industry, having 1.5 B$ turnover and 2.5 B$ market cap in the Tel-Aviv stock exchange. He is also the chairman of the board of the Lycored group and of Galam industries. Galam is a leading manufacturer of fructose and starch and a major shareholder of Enzymotec.
"We are excited from the joining of Mr. Leviteh to the management team of Enzymotec and we are certain that his past record and experience in the life science business will boost our abilities to grow rapidly as a leading manufacturer of advanced lipids for health" says Dr. Ariel Katz, Enzymotec CEO.
Enzymotec is an Israeli biotech company, that is developing and producing health ingredients for dietary supplements and functional foods.
The company's leading product categories are: InFat for balanced nutrition in infant formula, SharpPS for cognitive performance improvement of seniors and CardiaBeat offering a broad health effect to reduce CVD risks.